ArticlePakistan journal of medical sciences2025
Effect of hybrid blood purification on nutritional status, inflammation, and cardiovascular events in patients with end-stage renal disease.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the effects of hybrid blood purification on nutritional status and cardiovascular events in patients with end-stage renal disease (ESRD). Methods: A total of 135 patients with ESRD who received treatment in The Affiliated Nanhua Hospital of Hengyang Medical School from March 2021 to June 2023 were included in this retrospective study. Of them, 66 patients were treated with hemodialysis purification (hemodialysis group), and 69 patients underwent hybrid blood purification (hybrid group). Renal function status, inflammatory cytokine levels, nutritional status, and incidence of cardiovascular events in two groups were compared. Results: After the treatment, levels of urea nitrogen and blood creatinine in both groups decreased compared to before the treatment, and was significantly lower in the hybrid group compared to the hemodialysis group (P<0.05). Serum levels of interleukin 6 (IL-6), high sensitivity C-reactive protein (hs-CRP), and tumor necrosis factor α (TNF-α) in both groups decreased compared to before the treatment, and were significantly lower in the hybrid group (P<0.05). Levels of hemoglobin (Hb), albumin (Alb), and serum ferritin (SF) in both groups increased compared to pretreatment levels, and were significantly higher in the hybrid group (P<0.05). The incidence of cardiovascular events in the hybrid group (2.90%) was lower than that in the hemodialysis group (11.59%) (P<0.05). Conclusions: Hybrid blood purification can improve nutritional status and renal function of patients with ESRD, downregulate the expression of inflammatory factors, reduce the degree of inflammatory response, and reduce the risk of cardiovascular events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.